US Patent 9409966 Glucagon-like peptide-1 derivatives and their pharmaceutical use
Patent 9409966 was granted and assigned to Novo Nordisk on August, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9409966 Glucagon-like peptide-1 derivatives and their pharmaceutical use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
